ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO820

Left Ventricular Diastolic Dysfunction by Echocardiography Is a New Predictor of Delayed Graft Function

Session Information

Category: Transplantation

  • 2102 Transplantation: Clinical


  • Huo, Linhui, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
  • Jiang, Hongli, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

Diastolic dysfunction (DD) is a common complication among end-stage renal disease (ESRD) patients. The ratio of early transmitral flow velocity (E) to early diastolic velocity (e') of the mitral annulus (E/e') is related to left ventricular (LV) diastolic dysfunction (LVDD). Delayed graft function (DGF) is a detrimental complication after kidney transplantation (KT). It is unclear whether increased E/e' predisposes a recipient to DGF.


A total of 574 patients were enrolled in this retrospective study. Two-dimensional echocardiography and Doppler imaging were performed. Multivariate logistic regression analyses were performed to calculate the OR (95%CI) for DGF. Model 1 included variables with P<0.05 in the multivariate logistic regression analyses. Model 2 was adjusted for demographic data (age and sex) and operation data (warm ischemia time and cold ischemia time). Model 3 (reference model) includes all the variables in Model 2 except E/e'. Discrimination was assessed by AUCs. Model performance was also evaluated by continuous net reclassification index (cNRI) and integrated discrimination improvement (IDI).


93 patients (16.25%) developed DGF. E/e' was higher in DGF patients(14.07±6.16 vs. 11.51±4.23, P<0.001). Per 1 unit E/e' increase (OR 1.16; 95%CI, 1.1-1.23) and higher E/e' categories (8≤E/e' ≤14 OR 6.51; 95%CI, 2.38-17.80; E/e' >14 OR 6.58; 95%CI, 2.39-17.97) were associated with DGF. After adjusting for other covariates, the relationship between E/e' and DGF remained significant (adjusted OR 1.13; 95%CI, 1.07-1.18). Compared with Model 3, Model 2 had better discrimination and reclassification (cNRI, 46.48%; 95% CI, 24.61%- 68.34%; IDI, 4.36%; 95% CI, 1.81%-6.91%).


Our study found that higher E/e' was an independent predictor of DGF. This may provide an important perspective on the management of waiting list patients. Our results recommend that clinicians should take measures to lower E/e' before transplantation to lower DGF risks.